Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)

ClinicalTrials.gov ID: NCT02215252

Public ClinicalTrials.gov record NCT02215252. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 3:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Double Blind Placebo And Active Controlled Parallel Group Phase 2 Study To Evaluate PF-05089771 As A Monotherapy And As An Add-on To Pregabalin For The Treatment Of Painful Diabetic Peripheral Neuropathy

Study identification

NCT ID
NCT02215252
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
141 participants

Conditions and interventions

Interventions

  • PF-05089771 150 mg Drug
  • Matched placebo for PF-05089771 150 mg and pregabalin 300 mg Drug
  • Pregabalin 300 mg Drug
  • PF-05089771 150 mg + Pregabalin 300 mg Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 9, 2014
Primary completion
Jul 14, 2015
Completion
Sep 27, 2015
Last update posted
May 4, 2017

2014 – 2015

United States locations

U.S. sites
32
U.S. states
13
U.S. cities
27
Facility City State ZIP Site status
Clinical Research Consortium Arizona Phoenix Arizona 85003
Arizona Research Center Phoenix Arizona 85023
Neuro-Pain Medical Center Fresno California 93710
Meridien Research Bradenton Florida 34208
PAB Clinical Research Brandon Florida 33511
Pulmonary Associates of Brandon (PAB) Brandon Florida 33511
Meridien Research Brooksville Florida 34601
Clinical Physiology Associates Fort Myers Florida 33912
MD Clinical Hallandale Florida 33009
Meridien Research Lakeland Florida 33805
Family Care Specialists Ocala Florida 34471
Renstar Medical Research Ocala Florida 34471
Oviedo Medical Research, LLC Oviedo Florida 32765
Meridien Research St. Petersburg Florida 33709
Meridien Research Tampa Florida 33634
Metabolic Research Institute, Inc West Palm Beach Florida 33401
Columbus Regional Research Institute Columbus Georgia 31904
Clinical Research Advantage, Inc Evansville Indiana 47714
Brigham and Women's Hospital Boston Massachusetts 02115
Novex Clinical Research, LLC New Bedford Massachusetts 02740
Beacon Clinical Research, LLC Quincy Massachusetts 02169
Michigan Head Pain and Neurological Institute Ann Arbor Michigan 48104
Clinical Research Consortium Las Vegas Nevada 89119
The Medical Research Network, LLC New York New York 10128
New Phase Research and Development Knoxville Tennessee 37919
Internal Medicine Associates Tullahoma Tennessee 37388
Trinity Clinical Research, LLC Tullahoma Tennessee 37388
KRK Medical Research Arlington Texas 76012
Nerve and Muscle Center of Texas Houston Texas 77030
National Clinical Research - Norfolk, Inc Norfolk Virginia 23502
Eastern Virginia Medical School Norfolk Virginia 23510
Rainier Clinical Research Center, Inc Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02215252, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2017 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02215252 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →